Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Christopher J WheelerKeith L Black

Abstract

Although the development of immune-based therapies for various cancers including malignant glioma has been heralded with much hope and optimism, objective clinical improvements in most vaccinated cancer patients have not been realized. To broaden the search for vaccine-induced benefits, we examined synergy of vaccines with conventional chemotherapy. Survival and progression times were analyzed retrospectively in 25 vaccinated (13 with and 12 without subsequent chemotherapy) and 13 nonvaccinated de novo glioblastoma (GBM) patients receiving chemotherapy. Immune responsiveness and T-cell receptor excision circle (TREC) content within CD8+ T cells (CD8+ TRECs) was determined in vaccinated patients. Vaccinated patients receiving subsequent chemotherapy exhibited significantly longer times to tumor recurrence after chemotherapy relative to their own previous recurrence times, as well as significantly longer postchemotherapy recurrence times and survival relative to patients receiving isolated vaccination or chemotherapy. Patients exhibiting objective (>50%) tumor regression, extremely rare in de novo GBM, were also confined to the vaccine + chemotherapy group. Prior tumor behavior, demographic factors, other treatment variables, dis...Continue Reading

References

Dec 15, 1991·Journal of Immunological Methods·P Matzinger
May 1, 1989·Journal of Neurosurgery·M S EdwardsP Silver
May 1, 1993·Neurosurgery·K L ChandlerC B Wilson
May 5, 1993·Journal of the National Cancer Institute·R S Kaplan
Apr 10, 1997·International Journal of Cancer. Journal International Du Cancer·E JägerA Knuth
May 1, 1997·Neurology·R GrantL Junck
Jun 15, 1999·Immunity·B D JamiesonJ A Zack
Jan 11, 2001·The New England Journal of Medicine·L M DeAngelis
Jun 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·L FongE G Engleman
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·G A OhnmachtF M Marincola
Jun 6, 2003·The Cancer Journal·Stephen J Hentschel, Frederick F Lang
Oct 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher J WheelerPaul K Lee
Mar 18, 2006·Hormone Research·Tina DusekMirko Korsic

❮ Previous
Next ❯

Citations

May 20, 2008·Cancer Immunology, Immunotherapy : CII·Rupal RamakrishnanDmitry I Gabrilovich
Jul 3, 2008·Cancer Immunology, Immunotherapy : CII·Jun WeiAmy B Heimberger
Aug 16, 2008·Cancer Immunology, Immunotherapy : CII·Constantin N BaxevanisMichael Papamichail
Oct 27, 2010·Cancer Immunology, Immunotherapy : CII·Rupal Ramakrishnan, Dmitry I Gabrilovich
Feb 14, 2009·Neurosurgical Review·Ryuya Yamanaka
Oct 29, 2004·Current Treatment Options in Oncology·Allen K SillsJay Weimar
Mar 26, 2008·Current Treatment Options in Oncology·Sunit DasKenji Muro
Sep 22, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yohei MineharuMaria G Castro
Apr 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gwendalyn D KingPedro R Lowenstein
Aug 27, 2010·Current Opinion in Oncology·Pierre-Yves DietrichPaul R Walker
Dec 23, 2011·Clinical & Developmental Immunology·Christopher JacksonMichael Lim
Dec 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert M PrinsLinda M Liau
Jun 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yohei MineharuMaria G Castro
Jul 7, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sylvia AdamsSandra Demaria
Jun 5, 2008·The Journal of Clinical Investigation·Laurence ZitvogelGuido Kroemer
Mar 18, 2010·The Journal of Clinical Investigation·Rupal RamakrishnanDmitry I Gabrilovich
Oct 16, 2010·Journal of Translational Medicine·Michelle J HickeyCarol A Kruse
May 25, 2007·Neuro-oncology·Thomas-Toan TranDarren H Wong
Jan 20, 2006·Journal of Zhejiang University. Science. B·Jamal A Khan, Sharmin Yaqin
Aug 27, 2009·Biologics : Targets & Therapy·Michael P GustafsonAllan B Dietz
Apr 3, 2009·Journal of Neurosurgery. Pediatrics·James L FrazierGeorge I Jallo
May 17, 2011·Journal of Neurosurgery·John H SampsonKevin A Schulman
Aug 13, 2010·Clinical Medicine Insights. Oncology·Joseph F Murphy
Jul 24, 2014·CNS Oncology·Alissa A ThomasCamilo E Fadul
Feb 1, 2011·Therapeutic Delivery·Jhanelle Gray, Alberto Chiappori
Aug 27, 2013·CNS Oncology·Ryan CordnerChristopher J Wheeler
May 30, 2014·The Lancet Oncology·Sébastien AnguilleZwi N Berneman
Jun 5, 2014·Cancer Immunology, Immunotherapy : CII·Emmanuel JouanneauChristopher J Wheeler
Aug 5, 2009·Critical Reviews in Clinical Laboratory Sciences·Constantin N BaxevanisMichael Papamichail
Apr 29, 2009·Expert Review of Vaccines·Xiaochuan ChenDavid M Goldenberg
Oct 23, 2012·Expert Review of Neurotherapeutics·Stefaan Van Gool, Steven De Vleeschouwer
Jul 20, 2005·Expert Review of Neurotherapeutics·Yasuharu AkasakiJohn S Yu
Apr 12, 2007·Expert Review of Neurotherapeutics·Richard G EversonJohn H Sampson
May 5, 2011·Expert Review of Neurotherapeutics·Hideho Okada, Ian F Pollack
Oct 14, 2005·Expert Review of Anticancer Therapy·S Farzana Hussain, Amy B Heimberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.